DBF4B and glioblastoma: The results showed that the difference of DBF4B expression in 24 cancers was significant, and the expression was upregulated in 11 cancers, and the expression of DBF4B was lower in ACC, GBM, KICH, LAML, LGG, OV, PRAD, READ, TGCT, THCA, UCEC, and UCS than that in paraneoplastic tissues (Figure 1B).